Repository logo
 

Faculty of Applied Sciences

Permanent URI for this communityhttp://ir-dev.dut.ac.za/handle/10321/5

Browse

Has files: YesSubject: search.filters.subject.Microencapsulation

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Microencapsulation of Bifidobacterium animalis and Lactobacillus casei using resistant starch from Vigna unguiculata
    (2020) Rengadu, Danielle; Mellem, John Jason
    The use of functional foods is increasing globally with individuals aiming to maintain a healthy gut causing an increasing trend associated with probiotics in the health sector. Probiotics are live microorganisms that aid in improving the digestive system and gut health, however, the main problem associated with probiotics are ensuring a safe delivery through transition to the colon in harsh gastrointestinal conditions. For probiotics to be considered effective to the host a growth of Log 7 is essential in the colon, thus the need for microencapsulation. Therefore, this study was aimed at analysing resistant starch isolated from cowpea as an encapsulation material for Lactobacillus casei and Bifidobacterium animalis, for beverage application. Five different cultivars of cowpea (Bechuana white, Fahari, PAN 311, TVU 11424 and DT129-4) were analysed to determine the amount of resistant starch yielded as well as structural and physicochemical properties to determine the most suitable cultivar for the encapsulation process. The resistant starch percentage obtained was found in the range of 9.42-13.74%, with DT129-4 yielding the most resistant starch. The structural and physicochemical results obtained showed that the resistant starch isolated from cowpea has the potential for microencapsulation with cultivar DT129-4 exhibiting the most favourable results. Resistant starch was used as an encapsulating medium for Lactobacillus casei (RSL), Bifidobacterium animalis (RSB) and for a combination of the two probiotic microorganisms (RSLB) at a ratio of 1:1. The encapsulation yield after freeze drying were between 81.55-88.78% with the viability of the microcapsules under simulated gastrointestinal conditions also observed. The microcapsules were added to apple juice and the viability and stability of the microcapsules examined over 28 d. The final viability for microcapsules in the juice at the end of 28 d for RSL, RSB and RSLB were 7.53, 6.98 and 7.46 Log CFU/mL. This study shows that that resistant starch from cowpea has great potential as an encapsulating membrane within the nutraceutical beverage manufacturing industry.
  • Thumbnail Image
    Item
    Improving the survival of probiotic in simulated conditions and azoxymethane-induced colon tumour bearing mice using modified citrus pectin-alginate microencapsulation
    (PKP Publishing Services Network, 2016) Odun-Ayo, Frederick Oluwasheyi; Mellem, John Jason; Reddy, Lalini
    Background: For a probiotic to be viable it needs to be preserved at a recommended minimum level of 6–7 log10cfu/g in the product being consumed, as suggested by the International Dairy Federation. Different biopolymer matrices have been used for encapsulation of probiotic; however, loss of viability is still a challenge. Materials and Methods: Modified citrus pectin-alginate microbeads containing Lactobacillus acidophilus ATCC 4356 was developed. Efficiency of the microbeads was evaluated in simulated conditions of the gastrointestinal tract and in Balb/c mice induced with colon tumor. Genomic identification of faecal lactobacilli samples from treated mice was also performed. Results: The Modified citrus pectin-alginate probiotic microbeads significantly enhanced the viability of Lactobacillus acidophilus ATCC 4356 compared to the control (p< 0.05) both in vitro and in vivo. Exposure of the modified citrus pectin-alginate microbeads to 3 hours of simulated gastric juice resulted in 82.7% survival of L. acidophilus ATCC 4356. Also, the number of faecal lactobacilli in the modified citrus pectin-alginate probiotic treated mice increased by 10.2% after 28 days. Conclusion: Modified citrus pectin-alginate is a novel effective means of oral delivery of bacterial cells and bioactive compounds. Modified citrus pectin-alginate can be used in probiotic therapy which may improve the prevention of colon cancer.